Humacyte, Inc. (HUMA)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 12:04PM EDT. Market open.
Loading interactive chart…
- Simply Wall St.
This Humacyte Insider Increased Their Holding By 91% Last Year
From what we can see, insiders were net buyers in Humacyte, Inc.'s ( NASDAQ:HUMA ) during the past 12 months. That is...
- GlobeNewswire
Humacyte to Participate at Upcoming Investor Conferences in May
DURHAM, N.C., May 13, 2024 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissue at commercial scale, today announced that Laura Niklason, M.D., Ph.D., Founder, President, and Chief Executive Officer, Dale Sander, Chief Financial Officer, and B.J. Scheessele, Chief Commercial Officer, will represent Humacyte at the following conferences in May. H.C. Wainwright BioConnect Investor Conferenc
- GuruFocus.com
Humacyte Inc (HUMA) Q1 2024 Earnings: Aligns with Analyst Projections Amid Strategic Advances
Key Financial and Operational Highlights from the First Quarter
© 2024 Yahoo. All rights reserved.